Back
Aptevo Therapeutics Stock Predictions
Sponsored
APVO
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
34
APVO
Aptevo Therapeutics
Last Price:
$5.14
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereAptevo Therapeutics Stock Forecast
-
Over the next 52 weeks, Aptevo Therapeutics has on average historically risen by 9.4% based on the past 8 years of stock performance.
-
Aptevo Therapeutics has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Aptevo Therapeutics Stock Undervalued?The current Aptevo Therapeutics [APVO] share price is $5.11. The Score for APVO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Aptevo Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Aptevo Therapeutics has on average historically risen by 9.4% based on the past 8 years of stock performance.
Aptevo Therapeutics Stock Rating
Sell
34
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics overpriced?
-
Aptevo Therapeutics has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Aptevo Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aptevotherapeutics.com
52-Week Data
52-Week High:
399.60
52-Week Low:
3.65
Prediction Charts
Market Cap:
2.6M
Price in USD:
5.11
Volume:
159.1K
Beta:
4.52
Technical Analysis
SMA50:
8.68
SMA100:
9.68
SMA200:
30.08
52-Wk Change:
-98.35%
Stock Predictions
-
Is Aptevo Therapeutics stock public?Yes, Aptevo Therapeutics is a publicly traded company.
-
What is the Aptevo Therapeutics stock quote today?The Aptevo Therapeutics stock price is 5.11 USD today.
-
How to buy Aptevo Therapeutics stock online?You can buy Aptevo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-6 | 8.86 | 9.98 | 10.39 | 8.85 |
Dec-9 | 9.64 | 8.73 | 9.64 | 8.72 |
Dec-10 | 8.86 | 9.20 | 9.34 | 8.50 |
Dec-11 | 9.21 | 10.01 | 11.18 | 9.05 |
Dec-12 | 11.48 | 5.63 | 14.90 | 5.30 |
Dec-13 | 5.76 | 4.09 | 5.95 | 4.08 |
Dec-16 | 4.10 | 3.88 | 4.61 | 3.65 |
Dec-17 | 3.84 | 4.20 | 4.78 | 3.84 |
Dec-18 | 4.28 | 4.29 | 4.90 | 4.21 |
Dec-19 | 4.71 | 4.53 | 4.71 | 4.20 |
Dec-20 | 4.68 | 4.36 | 4.73 | 4.23 |
Dec-23 | 4.46 | 4.71 | 4.71 | 4.29 |
Dec-24 | 4.71 | 4.84 | 4.97 | 4.60 |
Dec-26 | 4.86 | 5.11 | 5.19 | 4.85 |
Aptevo Therapeutics Earnings
Aptevo Therapeutics Earnings Report: Per Share Aptevo Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aptevo Therapeutics Forecast Revenue Growth
Aptevo Therapeutics Stock Analysis: Historical quarterly revenues per share for Aptevo Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.